Additional studies are required to validate the concomitant induction of pro-death/pro-survival signaling by DR5-selective targeting in vivo and whether sustained treatment with selective ligands could shift the tumoricidal effect towards tumor promotion. Here, TNFRSF10B is linked to neoplasm.